A surveillance of previously untreated patients for possible virus transmission by BPL Factor 8 and Factor 9 Concentrates, 8Y and 9A, was carried out in September 1986.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Viral Inactivation
Key Person(s)
Baroness Jean Alys Barker DCVO PC